TVARDI THERAPEUTICS, INC. (TVRD) Total liabilities 2016–2024
TVARDI THERAPEUTICS, INC. (TVRD) total liabilities at each fiscal year-end, per SEC filings.
$40.8MFY2024 · since FY2016: $13.1M → $40.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $40.8M | -40.6% |
| FY2023 | $68.8M | +193.1% |
| FY2022 | $23.5M | +20.1% |
| FY2021 | $19.5M | -11.8% |
| FY2020 | $22.2M | -52.1% |
| FY2019 | $46.2M | -19.1% |
| FY2018 | $57.2M | +459.4% |
| FY2017 | $10.2M | -22.0% |
| FY2016 | $13.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Operating cash flowTVRD Free cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Shareholders’ equityTVRD overview →